|
1
|
Lee EJ, Lee JB, Lee SH and Youk EG:
Endoscopic treatment of large colorectal tumors: Comparison of
endoscopic mucosal resection, endoscopic mucosal
resection-precutting and endoscopic submucosal dissection. Surg
Endosc. 26:2220–2230. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tanaka S, Oka S, Kaneko I, Hirata M, Mouri
R, Kanao H, Yoshida S and Chayama K: Endoscopic submucosal
dissection for colorectal neoplasia: Possibility of
standardization. Gastrointest Endosc. 66:100–107. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kobayashi N, Saito Y, Uraoka T, Matsuda T,
Suzuki H and Fujii T: Treatment strategy for laterally spreading
tumors in Japan: Before and after the introduction of endoscopic
submucosal dissection. J Gastroenterol Hepatol. 24:1387–1392. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Miyachi H, Kudo SE, Ichimasa K, Hisayuki
T, Oikawa H, Matsudaira S, Kouyama Y, Kimura YJ, Misawa M, Mori Y,
et al: Management of T1 colorectal cancers after endoscopic
treatment based on the risk stratification of lymph node
metastasis. J Gastroenterol Hepatol. 31:1126–1132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kobayashi H, Mochizuki H, Morita T, Kotake
K, Teramoto T, Kameoka S, Saito Y, Takahashi K, Hase K, Oya M, et
al: Characteristics of recurrence after curative resection for T1
colorectal cancer: Japanese multicenter study. J Gastroenterol.
46:203–211. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Son HJ, Song SY, Lee WY, Yang SS, Park SH,
Yang MH, Yoon SH and Chun HK: Characteristics of early colorectal
carcinoma with lymph node metastatic disease.
Hepatogastroenterology. 55:1293–1297. 2008.PubMed/NCBI
|
|
7
|
Hackelsberger A, Fruhmorgen P, Weiler H,
Heller T, Seeliger H and Junghanns K: Endoscopic polypectomy and
management of colorectal adenomas with invasive carcinoma.
Endoscopy. 27:153–158. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
AB III Benson, Bekaii-Saab T, Chan E, Chen
YJ, Choti MA, Cooper HS, Engstrom PF, Enzinger PC, Fakih MG, Fenton
MJ, et al: Localized colon cancer, version 3.2013: Featured updates
to the NCCN Guidelines. J Natl Compr Canc Netw. 11:519–528.
2013.PubMed/NCBI
|
|
9
|
Labianca R, Nordlinger B, Beretta GD,
Mosconi S, Mandalà M, Cervantes A and Arnold D; ESMO Guidelines
Working Group, : Early colon cancer: ESMO clinical practice
guidelines for diagnosis, treatment and follow-up. Ann Oncol. 24
Suppl 6:vi64–vi72. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Watanabe T, Itabashi M, Shimada Y, Tanaka
S, Ito Y, Ajioka Y, Hamaguchi T, Hyodo I, Igarashi M, Ishida H, et
al: Japanese Society for Cancer of the Colon and Rectum (JSCCR)
Guidelines 2014 for treatment of colorectal cancer. Int J Clin
Oncol. 20:207–239. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nakadoi K, Oka S, Tanaka S, Hayashi N,
Terasaki M, Arihiro K, Shimamoto F and Chayama K: Condition of
muscularis mucosae is a risk factor for lymph node metastasis in T1
colorectal carcinoma. Surg Endosc. 28:1269–1276. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kitajima K, Fujimori T, Fujii S, Takeda J,
Ohkura Y, Kawamata H, Kumamoto T, Ishiguro S, Kato Y, Shimoda T, et
al: Correlations between lymph node metastasis and depth of
submucosal invasion in submucosal invasive colorectal carcinoma: A
Japanese collaborative study. J Gastroenterol. 39:534–543. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wada H, Shiozawa M, Katayama K, Okamoto N,
Miyagi Y, Rino Y, Masuda M and Akaike M: Systematic review and
meta-analysis of histopathological predictive factors for lymph
node metastasis in T1 colorectal cancer. J Gastroenterol.
50:727–734. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Choi JY, Jung SA, Shim KN, Cho WY, Keum B,
Byeon JS, Huh KC, Jang BI, Chang DK, Jung HY, et al: Meta-analysis
of predictive clinicopathologic factors for lymph node metastasis
in patients with early colorectal carcinoma. J Korean Med Sci.
30:398–406. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Beaton C, Twine CP, Williams GL and
Radcliffe AG: Systematic review and meta-analysis of
histopathological factors influencing the risk of lymph node
metastasis in early colorectal cancer. Colorectal Dis. 15:788–797.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bosch SL, Teerenstra S, de Wilt JH,
Cunningham C and Nagtegaal ID: Predicting lymph node metastasis in
pT1 colorectal cancer: A systematic review of risk factors
providing rationale for therapy decisions. Endoscopy. 45:827–834.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mou S, Soetikno R, Shimoda T, Rouse R and
Kaltenbach T: Pathologic predictive factors for lymph node
metastasis in submucosal invasive (T1) colorectal cancer: A
systematic review and meta-analysis. Surg Endosc. 27:2692–2703.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Moher D, Liberati A, Tetzlaff J and Altman
DG; PRISMA Group, : Preferred reporting items for systematic
reviews and meta-analyses: The PRISMA statement. PLoS Med.
6:e10000972009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Higgins J and Green S: Cochrane Handbook
for Systematic Reviews of Interventions Version 5.1.0 [updated
March 2011]. 2008. The Cochrane Collaboration; 2011
|
|
20
|
Hayden JA, van der Windt DA, Cartwright
JL, Côté P and Bombardier C: Assessing bias in studies of
prognostic factors. Ann Intern Med. 158:280–286. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Iorio A, Spencer FA, Falavigna M, Alba C,
Lang E, Burnand B, McGinn T, Hayden J, Williams K, Shea B, et al:
Use of GRADE for assessment of evidence about prognosis: Rating
confidence in estimates of event rates in broad categories of
patients. BMJ. 350:h8702015. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Umemura K, Takagi S, Shimada T, Masuda T,
Shiga H, Takahashi S, Takahashi S, Kinouchi Y, Shibuya D and
Shimosegawa T: Prognostic and diagnostic significance of tumor
budding associated with β-catenin expression in submucosal invasive
colorectal carcinoma. Tohoku J Exp Med. 229:53–59. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kobayashi H, Mochizuki H, Kato T, Mori T,
Kameoka S, Shirouzu K, Saito Y, Watanabe M, Morita T, Hida J, et
al: Is total mesorectal excision always necessary for T1-T2 lower
rectal cancer? Ann Surg Oncol. 17:973–980. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yamamoto S, Watanabe M, Hasegawa H, Baba
H, Yoshinare K, Shiraishi J and Kitajima M: The risk of lymph node
metastasis in T1 colorectal carcinoma. Hepatogastroenterology.
51:998–1000. 2004.PubMed/NCBI
|
|
25
|
Chan AW, Hróbjartsson A, Haahr MT,
Gøtzsche PC and Altman DG: Empirical evidence for selective
reporting of outcomes in randomized trials: Comparison of protocols
to published articles. J Am Med Assoc. 291:2457–2465. 2004.
View Article : Google Scholar
|
|
26
|
Kikuchi R, Takano M, Takagi K, Fujimoto N,
Nozaki R, Fujiyoshi T and Uchida Y: Management of early invasive
colorectal cancer. Risk of recurrence and clinical guidelines. Dis
Colon Rectum. 38:1286–1295. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Arai T, Akiyama Y, Yamamura A, Hosoi T,
Shibata T, Saitoh K, Okabe S and Yuasa Y: Allelotype analysis of
early colorectal cancers with lymph node metastasis. Int J Cancer.
79:418–423. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bayar S, Saxena R, Emir B and Salem RR:
Venous invasion may predict lymph node metastasis in early rectal
cancer. Eur J Surg Oncol. 28:413–417. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shimomura T, Ishiguro S, Konishi H,
Wakabayashi N, Mitsufuji S, Kasugai T, Manou M and Kodama T: New
indication for endoscopic treatment of colorectal carcinoma with
submucosal invasion. J Gastroenterol Hepatol. 19:48–55. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hahnloser D, Wolff BG, Larson DW, Ping J
and Nivatvongs S: Immediate radical resection after local excision
of rectal cancer: An oncologic compromise? Dis Colon Rectum.
48:429–437. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kawamura YJ, Sakuragi M, Togashi K, Okada
M, Nagai H and Konishi F: Distribution of lymph node metastasis in
T1 sigmoid colon carcinoma: Should we ligate the inferior
mesenteric artery? Scand J Gastroenterol. 40:858–861. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kojima M, Shiokawa A, Ohike N, Ohta Y,
Kato H, Iwaku K, Hayasi R and Morohoshi T: Clinical significance of
nuclear morphometry at the invasive front of T1 colorectal cancer
and relation to expression of VEGF-A and VEGF-C. Oncology.
68:230–238. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang HS, Liang WY, Lin TC, Chen WS, Jiang
JK, Yang SH, Chang SC and Lin JK: Curative resection of T1
colorectal carcinoma: Risk of lymph node metastasis and long-term
prognosis. Dis Colon Rectum. 48:1182–1192. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Abe A, Fukui H, Fujii S, Fujita M, Mukawa
K, Ichikawa K, Tomita S, Ono Y, Imai Y, Imura J, et al: Involvement
of cyclooxygenase-2 and vascular endothelial growth factor in
vascularization and lymph node metastasis of colorectal cancers
with submucosal invasion. J Gastroenterol Hepatol. 22:1071–1077.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yasuda K, Inomata M, Shiromizu A,
Shiraishi N, Higashi H and Kitano S: Risk factors for occult lymph
node metastasis of colorectal cancer invading the submucosa and
indications for endoscopic mucosal resection. Dis Colon Rectum.
50:1370–1376. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ishikawa Y, Akishima-Fukasawa Y, Ito K,
Akasaka Y, Yokoo T and Ishii T: Toho Study Group for Cancer
Biological Behavior: Histopathologic determinants of regional lymph
node metastasis in early colorectal cancer. Cancer. 112:924–933.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kim JH, Cheon JH, Kim TI, Baik SH, Kim NK,
Kim H and Kim WH: Effectiveness of radical surgery after incomplete
endoscopic mucosal resection for early colorectal cancers: A
clinical study investigating risk factors of residual cancer. Dig
Dis Sci. 53:2941–2946. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ishii M, Ota M, Saito S, Kinugasa Y,
Akamoto S and Ito I: Lymphatic vessel invasion detected by
monoclonal antibody D2-40 as a predictor of lymph node metastasis
in T1 colorectal cancer. Int J Colorectal Dis. 24:1069–1074. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Akishima-Fukasawa Y, Ishikawa Y, Akasaka
Y, Uzuki M, Inomata N, Yokoo T, Ishii R, Shimokawa R, Mukai K,
Kiguchi H, et al: Histopathological predictors of regional lymph
node metastasis at the invasive front in early colorectal cancer.
Histopathology. 59:470–481. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kobayashi H, Higuchi T, Uetake H, Iida S,
Ishikawa T, Ishiguro M and Sugihara K: Resection with en bloc
removal of regional lymph node after endoscopic resection for T1
colorectal cancer. Ann Surg Oncol. 19:4161–4167. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kye BH, Jung JH, Kim HJ, Kang SG, Cho HM
and Kim JG: Tumor budding as a risk factor of lymph node metastasis
in submucosal invasive T1 colorectal carcinoma: A retrospective
study. BMC Surg. 12:2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Nasu T, Oku Y, Takifuji K, Hotta T,
Yokoyama S, Matsuda K, Tamura K, Ieda J, Yamamoto N, Takemura S, et
al: Predicting lymph node metastasis in early colorectal cancer
using the CITED1 expression. J Surg Res. 185:136–142. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wada H, Shiozawa M, Sugano N, Morinaga S,
Rino Y, Masuda M, Akaike M and Miyagi Y: Lymphatic invasion
identified with D2-40 immunostaining as a risk factor of nodal
metastasis in T1 colorectal cancer. Int J Clin Oncol. 18:1025–1031.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Nishida T, Egashira Y, Akutagawa H, Fujii
M, Uchiyama K, Shibayama Y and Hirose Y: Predictors of lymph node
metastasis in T1 colorectal carcinoma: An immunophenotypic analysis
of 265 patients. Dis Colon Rectum. 57:905–915. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ryu HS, Kim WH, Ahn S, Kim DW, Kang SB,
Park HJ, Park YS, Lee CH and Lee HS: Combined morphologic and
molecular classification for predicting lymph node metastasis in
early-stage colorectal adenocarcinoma. Ann Surg Oncol.
21:1809–1816. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kang J, Lee HW, Kim IK, Kim NK, Sohn S-K
and Lee KY: Clinical implications of microsatellite instability in
T1 colorectal cancer. Yonsei Med J. 56:175–181. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kawachi H, Eishi Y, Ueno H, Nemoto T,
Fujimori T, Iwashita A, Ajioka Y, Ochiai A, Ishiguro S, Shimoda T,
et al: A three-tier classification system based on the depth of
submucosal invasion and budding/sprouting can improve the treatment
strategy for T1 colorectal cancer: A retrospective multicenter
study. Mod Path. 28:872–879. 2015. View Article : Google Scholar
|
|
48
|
Macias-Garcia F, Celeiro-Muñoz C,
Lesquereux-Martinez L, Gude-Sampedro F, Uribarri-Gonzalez L,
Abdulkader I, Alvarez-Castro A and Dominguez-Muñoz JE: A clinical
model for predicting lymph node metastasis in submucosal invasive
(T1) colorectal cancer. Int J Colorectal Dis. 30:761–768. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Sohn DK, Chang HJ, Park JW, Choi DH, Han
KS, Hong CW, Jung KH, Kim DY, Lim SB, Choi HS and Jeong SY:
Histopathological risk factors for lymph node metastasis in
submucosal invasive colorectal carcinoma of pedunculated or
semipedunculated type. J Clin Pathol. 60:912–915. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Morodomi T, Isomoto H, Shirouzu K,
Kakegawa K, Irie K and Morimatsu M: An index for estimating the
probability of lymph node metastasis in rectal cancers. Lymph node
metastasis and the histopathology of actively invasive regions of
cancer. Cancer. 63:539–543. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Walgenbach-Bruenagel G, Tolba RH, Varnai
AD, Bollmann M, Hirner A and Walgenbach KJ: Detection of lymphatic
invasion in early stage primary colorectal cancer with the
monoclonal antibody D2-40. Eur Surg Res. 38:438–444. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Kahn HJ and Marks A: A new monoclonal
antibody, D2-40, for detection of lymphatic invasion in primary
tumors. Lab Invest. 82:1255–1257. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Kahn HJ, Bailey D and Marks A: Monoclonal
antibody D2-40, a new marker of lymphatic endothelium, reacts with
Kaposi's sarcoma and a subset of angiosarcomas. Mod Pathol.
15:434–440. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
La Vecchia C and Franceschi S:
Reproductive factors and colorectal cancer. Cancer Causes Control.
2:193–200. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Fernandez E, La Vecchia C, Balducci A,
Chatenoud L, Franceschi S and Negri E: Oral contraceptives and
colorectal cancer risk: A meta-analysis. Br J Cancer. 84:722–727.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Grodstein F, Newcomb PA and Stampfer MJ:
Postmenopausal hormone therapy and the risk of colorectal cancer: A
review and meta-analysis. Am J Med. 106:574–582. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Hendifar A, Yang D, Lenz F, Lurje G, Pohl
A, Lenz C, Ning Y, Zhang W and Lenz HJ: Gender disparities in
metastatic colorectal cancer survival. Clin Cancer Res.
15:6391–6397. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Newcomb PA, Zheng Y, Chia VM, Morimoto LM,
Doria-Rose VP, Templeton A, Thibodeau SN and Potter JD: Estrogen
plus progestin use, microsatellite instability, and the risk of
colorectal cancer in women. Cancer Res. 67:7534–7539. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Walter P, Green S, Greene G, Krust A,
Bornert JM, Jeltsch JM, Staub A, Jensen E, Scrace G, Waterfield M,
et al: Cloning of the human estrogen receptor cDNA. Proc Natl Acad
Sci USA. 82:7889–7893. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Kuiper GG, Enmark E, Pelto-Huikko M,
Nilsson S and Gustafsson JA: Cloning of a novel receptor expressed
in rat prostate and ovary. Proc Natl Acad Sci USA. 93:5925–5930.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Barone M, Scavo MP, Papagni S, Piscitelli
D, Guido R, Di Lena M, Comelli MC and Di Leo A: ERβ expression in
normal, adenomatous and carcinomatous tissues of patients with
familial adenomatous polyposis. Scand J Gastroenterol.
45:1320–1328. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Konstantinopoulos PA, Kominea A, Vandoros
G, Sykiotis GP, Andricopoulos P, Varakis I, Sotiropoulou-Bonikou G
and Papavassiliou AG: Oestrogen receptor beta (ERbeta) is
abundantly expressed in normal colonic mucosa, but declines in
colon adenocarcinoma paralleling the tumour's dedifferentiation.
Eur J Cancer. 39:1251–1258. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Jassam N, Bell SM, Speirs V and Quirke P:
Loss of expression of oestrogen receptor beta in colon cancer and
its association with Dukes' staging. Oncol Rep. 14:17–21.
2005.PubMed/NCBI
|
|
64
|
Nüssler NC, Reinbacher K, Shanny N,
Schirmeier A, Glanemann M, Neuhaus P, Nussler AK and Kirschner M:
Gender-specific differences in the expression levels of estrogen
receptor subtypes in colorectal cancer. Gend Med. 5:209–217. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Foley EF, Jazaeri AA, Shupnik MA, Jazaeri
O and Rice LW: Selective loss of estrogen receptor beta in
malignant human colon. Cancer Res. 60:245–248. 2000.PubMed/NCBI
|
|
66
|
Roger P, Sahla ME, Mäkelä S, Gustafsson
JA, Baldet P and Rochefort H: Decreased expression of estrogen
receptor beta protein in proliferative preinvasive mammary tumors.
Cancer Res. 61:2537–2541. 2001.PubMed/NCBI
|
|
67
|
Shaw JA, Udokang K, Mosquera JM, Chauhan
H, Jones JL and Walker RA: Oestrogen receptors alpha and beta
differ in normal human breast and breast carcinomas. J Pathol.
198:450–457. 2002. View Article : Google Scholar : PubMed/NCBI
|
